Amy S. Beadles-Bohling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Amy S. Beadles-Bohling has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Kristine M. Wiren
Department of Behavioral Neuroscience
3 shared publications J.C. Crabbe
Portland Alcohol Research Center, Research Service P3-R&D-39, 3710 SW US Veteran’s Hospital Road, Oregon Health Sciences University, Portland, OR 97201, USA
1 shared publication
Latest Publications
- Open Access
- 8 August 2006
- Published by Wiley in Genes, Brain and Behavior
- Vol. 5 (6) , 483-496
Anticonvulsive effects of κ‐Opioid receptor modulation in an animal model of ethanol withdrawal
Although the neurochemical mechanisms contributing to alcohol withdrawal seizures are poorly understood, withdrawal seizures probably reflect neuronal hyperexcitability resulting from adaptation to chronic alcohol. Altered κ‐Opioid receptor (KOP‐R) signaling has been observed in multiple seizure types; however, a role for this system in ethanol withdrawal seizures has not been systematically characterized. We hypothesized that pharmacological manipulations of the KOP‐R would alter withdrawal in mice selectively bred for differences in ethanol withdrawal severity. Withdrawal Seizure‐Prone (WSP) and Withdrawal Seizure‐Resistant (WSR) mice were made physically dependent using chronic ethanol vapor inhalation, and the effects of the KOP‐R antagonist nor‐binaltorphimine or agonist U‐50,488H on withdrawal severity were examined. Pretreatment with nor‐binaltorphimine significantly increased handling‐induced convulsion (HIC) severity in withdrawing WSR mice, with no observable effects in withdrawing WSP mice. In contrast, U‐50,488H significantly decreased HIC severity in WSP mice, with no effects in WSR mice. During extended withdrawal (i.e. hours 12+), a rebound hyperexcitability was observed in WSP mice given agonist. Thus, administration of a KOP‐R antagonist increased withdrawal severity in mice normally resistant to withdrawal seizures, while a KOP‐R agonist reduced convulsion severity in animals susceptible to withdrawal seizures. These observations are consistent with differences in the KOP‐R system observed in these lines at the molecular level, and suggest the KOP‐R system may be a promising therapeutic target for management of ethanol withdrawal seizures. Finally, these findings underscore the importance of determining the potential for rebound increases in withdrawal severity during later withdrawal episodes.
- 8 August 2006
- Published by Wiley in Genes, Brain and Behavior
- Vol. 5 (6) , 483-496
Open AccessAnticonvulsive effects of κ‐Opioid receptor modulation in an animal model of ethanol withdrawal
Although the neurochemical mechanisms contributing to alcohol withdrawal seizures are poorly understood, withdrawal seizures probably reflect neuronal hyperexcitability resulting from adaptation to chronic alcohol. Altered κ‐Opioid receptor (KOP‐R) signaling has been observed in multiple seizure types; however, a role for this system in ethanol withdrawal seizures has not been systematically characterized. We hypothesized that pharmacological manipulations of the KOP‐R would alter withdrawal in mice selectively bred for differences in ethanol withdrawal severity. Withdrawal Seizure‐Prone (WSP) and Withdrawal Seizure‐Resistant (WSR) mice were made physically dependent using chronic ethanol vapor inhalation, and the effects of the KOP‐R antagonist nor‐binaltorphimine or agonist U‐50,488H on withdrawal severity were examined. Pretreatment with nor‐binaltorphimine significantly increased handling‐induced convulsion (HIC) severity in withdrawing WSR mice, with no observable effects in withdrawing WSP mice. In contrast, U‐50,488H significantly decreased HIC severity in WSP mice, with no effects in WSR mice. During extended withdrawal (i.e. hours 12+), a rebound hyperexcitability was observed in WSP mice given agonist. Thus, administration of a KOP‐R antagonist increased withdrawal severity in mice normally resistant to withdrawal seizures, while a KOP‐R agonist reduced convulsion severity in animals susceptible to withdrawal seizures. These observations are consistent with differences in the KOP‐R system observed in these lines at the molecular level, and suggest the KOP‐R system may be a promising therapeutic target for management of ethanol withdrawal seizures. Finally, these findings underscore the importance of determining the potential for rebound increases in withdrawal severity during later withdrawal episodes.
- 24 May 2005
- Published by Elsevier in Brain Research
- Vol. 1046 (1-2) , 77-89
Alteration of kappa-opioid receptor system expression in distinct brain regions of a genetic model of enhanced ethanol withdrawal severity
- 24 May 2005
- Published by Elsevier in Brain Research
- Vol. 1046 (1-2) , 77-89
Alteration of kappa-opioid receptor system expression in distinct brain regions of a genetic model of enhanced ethanol withdrawal severity
- 23 June 2000
- Published by Elsevier in Neurochemistry International
- Vol. 37 (5-6) , 463-472
Elevated prodynorphin expression associated with ethanol withdrawal convulsions
- 23 June 2000
- Published by Elsevier in Neurochemistry International
- Vol. 37 (5-6) , 463-472
Elevated prodynorphin expression associated with ethanol withdrawal convulsions